))
Episode 2: Pressors
Manage episode 407249559 series 3559098
Treść dostarczona przez Barrett Bowen and No Shock Advised Podcast. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Barrett Bowen and No Shock Advised Podcast lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
Welcome to the No Shock Advised Podcast with Brett and Matt.
This week: We’re discussing vasopressors (and inodilators): the what, the where, and the why. There’s a lot of ground to cover, so buckle up.
We have a form for asking questions here.
You can check us out on Facebook here.
You can email us @ NoShockAdvisedPodcast@gmail.com.
If you feel led, you can access our Patreon here.
References and Further Readings:
- Ninja Nerd: Vasopressors
- emDOCs: Evidence Based Approach to Pressors in Shock
- Resus: Cardiogenic Shock: Which Vasopressor to Use
- Relias Media: The Use of Vasopressors and Inotropes in the Emergency Department for the Treatment of Shock
- Levy, 2020: Vasopressor Use in Cardiogenic Shock
- Levy, 2019: Inotropes and Vasopressors Use in Cardiogenic Shock: When, Which, and How Much?
- Yue, 2019: Vasopressor Support in Managing Acute Spinal Cord Injury: Current Knowledge
- Ploumis, 2010: A systematic Review of the Evidence Supporting a Role for Vasopressor Support in Acute SCI
- Sedhai, 2022: Vasopressin Versus Norepinephrine as the First-Line Vasopressor in Septic Shock
- Kubena, 2022: Push-Dose Vasopressors in the Emergency Department
- Zotzmann, 2022: Obstructive Shock from Diagnosis to Treatment
- Ammar, 2022: Timing of Vasoactive Agents and Corticosteroid Initiation ins Septic Shock
- Sahoo, 2022: Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock
6 odcinków
Udostępnij
